Back to search

Article

An improved method to produce clinical scale natural killer cells from human pluripotent stem cells

2019-04-21

Abstract excerpt

Human natural killer (NK) cell-based adoptive anti-cancer immunotherapy has gained intense interest with many clinical trials actively recruiting patients to treat a variety of both hematological malignancies and solid tumors. Most of these trials use primary NK cells isolated either from peripheral blood (PB-NK cells) or umbilical cord blood (UCB-NK cells), though these sources require NK cell collection for each...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aebd2cec-7f2a-5088-a6ff-4bf84a59c9cc
DOI
10.1101/614792
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An improved method to produce clinical scale natural killer cells from human pluripotent stem cellsDOI 10.1101/614792
Select a neighboring publication to make it the new centre.